As DMOG is predicted to inhibit a broad spectrum of dioxygenases, including hydroxylases, it is possible that these enzymes have additional substrates with the ability to regulate aberrantly expressed cyclin D1 in MCL cells. This evidence concerns the gene CCND1 and mantle cell lymphoma.